A Practical and Chromatography-Free Process for Sabizabulin (VERU-111) via an Acylaminoisoxazole Intermediate
- 29 October 2026
- journal article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
Abstract
Sabizabulin (VERU-111) is an investigational colchicine-binding site microtubule inhibitor under consideration for clinical evaluation in metastatic pancreatic cancer. We report a scalable synthesis of sabizabulin from readily available 3,4,5-trimethoxybenzoic acid. The route was developed to address limitations in step economy, operational complexity, and scalability associated with previously reported approaches. An isoxazole fragment is introduced at an early stage and serves as a masked precursor to the imidazole core, allowing assembly of the target structure without protecting groups. The key transformation involves the two-step conversion of an acylaminoisoxazole to the corresponding acylimidazole by hydrogenation followed by cyclization. The optimized process is operationally simple and does not require chromatographic purification at any stage. The synthesis was demonstrated on a multigram scale, and sabizabulin was obtained in eight steps in 31% overall yield with a final purity of 99.2% by LC–UV.Keywords
This publication has 40 references indexed in Scilit:
- Brønsted Acid Promoted N ‐Dealkylation of N ‐Alkyl(sulfon)amidesChemistrySelect, 2021
- Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancerCancer Letters, 2020
- Deprotonation of Isoxazole: A Photoelectron Imaging StudyThe Journal of Physical Chemistry A, 2020
- VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathwayCancer Letters, 2020
- Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1H-Indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in TubulinJournal of Medicinal Chemistry, 2019
- Synthesis and antitumor activity of novel 6,7,8-trimethoxy N-aryl-substituted-4-aminoquinazoline derivativesBioorganic & Medicinal Chemistry Letters, 2018
- Preparation and reactivity of [2-(3-methyl-4-nitro-isoxazol-5-yl)-vinyl]-aminesTetrahedron Letters, 2015
- Formation of new C–O and C–N bonds via base promoted Csp2–Csp3 bond cleavage of α-nitro ketoneTetrahedron Letters, 2015
- Imidazoles: SAR and development of a potent class of cyclin-dependent kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Herstellung von substituierten 2‐Aminooxazol‐4‐carbonitrilenHelvetica Chimica Acta, 1989